Anaesthetic Management for Pheochromocytoma Surgery: A Never Ending Challenge
,
Abstract
Pheochromocytoma is a challenging case for any anesthesiologist and a team approach is required throughout the perioperative period to prevent anticipated difficulties and best manage any unforeseen complications that develop. We discuss successful management of certain unique challenges, like multifocal arrhythmias and surgical rebleed during transport, during pheochromocytoma surgery in an adult, in addition to the usual perioperative problems.
[1] Zelinka T, Eisenhofer G, Pacak K. Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice. Stress. 2007; 10(2):195-203.
[2] Connor D, Boumphrey S. Perioperative care of phaeochromocytoma, BJA Education. 2016; 16(5): 153–158.
[3] Mamilla D, Araque KA, Brofferio A, Gonzales MK, Sullivan JN, Nilubol N, et al. Postoperative Management in Patients with Pheochromocytoma and Paraganglioma. Cancers (Basel). 2019; 11(7):936.
[4] Schürmeyer TH, Engeroff B, Dralle H, von zur Mühlen A. Cardiological effects of catecholamine-secreting tumours. Eur J Clin Invest. 1997; 27(3):189-95.
[5] Prejbisz A, Lenders JW, Eisenhofer G, Januszewicz A. Cardiovascular manifestations of phaeochromocytoma. J Hypertens. 2011; 29(11):2049-60.
[6] Brouwers FM, Eisenhofer G, Lenders JW, Pacak K. Emergencies caused by pheochromocytoma, neuroblastoma, or ganglioneuroma. Endocrinol Metab Clin North Am. 2006; 35:699–724.
[7] Yu R, Furmark L, Wong C. Cardiac abnormalities associated with pheochromocytoma and other adrenal tumors. Endocr Pract. 2009; 15(1):10-6.
[8] Kulshrestha A, Singh J. Inter-hospital and intra-hospital patient transfer: Recent concepts. Indian J Anaesth. 2016; 60(7):451-7.
[2] Connor D, Boumphrey S. Perioperative care of phaeochromocytoma, BJA Education. 2016; 16(5): 153–158.
[3] Mamilla D, Araque KA, Brofferio A, Gonzales MK, Sullivan JN, Nilubol N, et al. Postoperative Management in Patients with Pheochromocytoma and Paraganglioma. Cancers (Basel). 2019; 11(7):936.
[4] Schürmeyer TH, Engeroff B, Dralle H, von zur Mühlen A. Cardiological effects of catecholamine-secreting tumours. Eur J Clin Invest. 1997; 27(3):189-95.
[5] Prejbisz A, Lenders JW, Eisenhofer G, Januszewicz A. Cardiovascular manifestations of phaeochromocytoma. J Hypertens. 2011; 29(11):2049-60.
[6] Brouwers FM, Eisenhofer G, Lenders JW, Pacak K. Emergencies caused by pheochromocytoma, neuroblastoma, or ganglioneuroma. Endocrinol Metab Clin North Am. 2006; 35:699–724.
[7] Yu R, Furmark L, Wong C. Cardiac abnormalities associated with pheochromocytoma and other adrenal tumors. Endocr Pract. 2009; 15(1):10-6.
[8] Kulshrestha A, Singh J. Inter-hospital and intra-hospital patient transfer: Recent concepts. Indian J Anaesth. 2016; 60(7):451-7.
| Files | ||
| Issue | Vol 9 No Supp. 1 (2023): Supplement 1 |
|
| Section | Case Report(s) | |
| DOI | https://doi.org/10.18502/aacc.v9i5.13967 | |
| Keywords | ||
| Pheochromocytoma catecholamine inotropes hypertension arrhythmias transport dysrhythmias | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Krishna B, Sharma K, Gandhi R, Yadav S. Anaesthetic Management for Pheochromocytoma Surgery: A Never Ending Challenge. Arch Anesth & Crit Care. 2023;9(Supp. 1):457-459.
